The Corporate Reputation of Pharma, 2017 - The Patient Perspective - Asia Edition

  • ID: 4664034
  • Report
  • Region: Asia
  • 76 pages
  • PatientView
1 of 5

FEATURED COMPANIES

  • AbbVie
  • Bayer
  • Eisai
  • GSK
  • Novartis
  • Roche
  • MORE

Introducing the results of the 2017 (2nd) edition of ‘The Corporate Reputation of Pharma-from the Perspective of Asian Patient Groups’. In total, 101 Asian patient groups from across the region participated in the 2017 survey (with 35% of the respondents being based in Australasia).

The 18 companies included in the 2017 Asia analysis are: AbbVie, Astellas Pharma, AstraZeneca, Bayer, Boehringer,ngelheim, Bristol-Myers Squibb, Eisai, Eli Lilly (Lilly), Gilead Sciences, GSK, Janssen, Merck & Co/MSD, Novartis, Otsuka, Pfizer, Roche, Sanofi, Takeda.
 
Asian patient groups (and the patients they represent), on the whole, take a more positive view of the pharmaceutical industry than patient groups from elsewhere in the world.   As many as 51% of the respondent Asian patient groups stated that the pharmaceutical industry as a whole had an “Excellent” or “Good” corporate reputation in 2017 (on a par with the 50% of Asian patient groups saying the same in 2016). The equivalent figure from patient groups worldwide in 2017 was 43%.

Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • AbbVie
  • Bayer
  • Eisai
  • GSK
  • Novartis
  • Roche
  • MORE

Executive Summary
The Relationships That Asian Patient Groups Have With Pharma, 2017
Industry-Wide Findings From Asian Patient Groups, 2017
Rankings Of The 18 Pharma Companies, 2017 V. 2016 Among Asian Patient Groups Familiar With The Companies
Positionings Of 11 Pharma Companies, 2017 V. 2016 Among Asian Patient Groups That Work/Partner With The Companies
Profiles Of The 18 Companies, 2017

Appendices
I. Asian Patient Groups: Their Views On Pharma And Their Recommendations For Improvement
II. Profiles Of The 101 Respondent Asian Patient Groups, 2017

Tables and Charts

Profile Of The 101 Asian Patient Groups By Country/Region, 2017
The Views That Asian Patient Groups Have On The Pharma Industry’S Performance At Innovation, And At The Provision Of High-Quality Products - Compared With The Views Of Patient Groups From 16 Other Countries/Regions, Plus All Respondent Patient Groups Worldwide, 2017
The Number Of Asian Patient Groups Familiar, And Partnering, With The 18 Companies, 2017
The Ways In Which The Pharmaceutical Companies Help Their Asian Patient-Group Partners, 2017
The Corporate Reputation Of The Pharmaceutical Industry, 2017 V. 2016-Compared With
That Of Seven Other Healthcare Sectors, According To Asian Patient Groups
The Views That Asian Patient Groups Have On The Pharmaceutical Industry’S Efficacy At
The Indicators Of Corporate Reputation, Plus At The Specific Activity Of Being Innovative, 2017-Chart and Table
The Views That Asian Patient Groups Have On The Pharmaceutical Industry’S Efficacy At The Indicators Of Corporate Reputation, Plus At The Specific Activity Of Being Innovative, 2017 V. 2016, V. The Views Of Patient Groups Worldwide, 2017
Rankings Of 18 Individual Pharma Companies, 2017 V. 2016 (According To Asian Patient Groups Familiar With The Company)
Positionings Of 11 Individual Pharma Companies, 2017 V. 2016 (According To Asian Patient Groups That Work/Partner With The Company)
Profiles Of The 18 Companies, 2017

CHARTS AND TABLES:
Number of respondent Asian patient groups claiming familiarity with the company, 2017.  
Number of respondent Asian patient groups saying that they had a working relationship with the company, 2017.
Company performance scores among respondent Asian patient groups familiar with the company, and which worked with the company, for each of the 12 indicators of corporate reputation, 2017.
Percentage of the respondent Asian patient groups that worked with the company, but which also worked with other companies, 2017.
Profile of respondent Asian patient groups familiar with the company, 2017: country headquarters; specialties; geographic remit; and the ways in which the company helps the
Asian patient groups that partner with it.
The company’s PCRIs (Patient Corporate Reputation Index) for each of the 12 indicators—as assessed by respondent Asian patient groups familiar with the company, 2017 v. 2016.  
Overall rankings for the company according to respondent Asian patient groups familiar with the company, 2017.
Overall positionings for the company-according to respondent Asian patient groups that work with the company, 2017.
Company rankings for each of the 12 indicators-according to respondent Asian patient groups familiar, or working, with the company, 2017 v. 2016.

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • AbbVie
  • Astellas Pharma
  • AstraZeneca
  • Bayer
  • Boehringer,ngelheim
  • Bristol-Myers Squibb
  • Eisai
  • Eli Lilly (Lilly)
  • GSK
  • Gilead Sciences
  • Janssen
  • Merck & Co/MSD
  • Novartis
  • Otsuka
  • Pfizer
  • Roche
  • Sanofi
  • Takeda
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll